IGC Pharma, Inc. Financial Ratios — IGC Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	03/31/2011	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025

Return on Common Equity (%)	-128.75	-72.09	-15.39	-21.54	-33.12	-20.27	-17.92	-23.16	-19.68	-24.34	-29.7	-52.97	-59.3	-116.95	-104.33
Return on Assets (%)	-75.62	-35.7	-10.12	-16.34	-24.24	-14.33	-12.39	-16.14	-18.08	-23.06	-27.17	-47.9	-52.29	-96.01	-76.37
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	3.91	-14.73	19.09	16.79	7.55	13.25	37.6	3.74	2.58	2.82	12.58	48.87	48.52	54.5	48.7
EBITDA Margin (%)	-174.86	-126.7	-18.79	-79.06	-46.36	-29.21	-285.52	-80.71	-89.6	-165.03	-918.26	-3,722.17	-1,198.02	-681.12	-549.33
Operating Margin (%)	-194.13	-150.43	-27.18	-110.4	-56.54	-40.65	-353.82	-81.58	-90.75	-168.57	-971.49	-3,886.15	-1,270.14	-728.48	-585.84
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-415.07	-184.47	-32.78	-133.85	-60.91	-44.5	-316.77	-81.44	-80.04	-179.64	-981.18	-3,782.37	-1,263.01	-966.54	-560.27
Profit Margin (%)	-496.84	-184.59	-28.05	-132.97	-60.08	-44.11	-321.74	-81.44	-80.08	-179.64	-981.18	-3,782.37	-1,263.01	-966.54	-560.27
Net Income to Common Margin (%)	-496.84	-184.59	-28.05	-132.97	-60.08	-44.11	-321.74	-81.44	-80.08	-179.64	-981.18	-3,782.37	-1,263.01	-966.54	-560.27
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-128.75	-72.09	-15.39	-21.54	-33.12	-20.27	-17.92	-23.16	-19.68	-24.34	-29.7	-52.97	-59.3	-116.95	-104.33

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	03/31/2011	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025

Total Debt	5	3	2	2	3	3	3	2	- -	1	1	1	- -	- -	- -
ST Debt	5	3	- -	- -	1	2	- -	2	- -	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	2	2	2	1	3	- -	- -	- -	1	- -	- -	- -	- -
Total Debt/EBITDA	-0.68	-0.48	-1.49	-1.24	-0.98	-1.52	-1.6	-1.26	-0.01	-0.08	-0.12	-0.04	-0.04	-0.04	-0.03
Net Debt/EBITDA	-0.45	-0.37	-0.78	-0.67	-0.75	-0.71	-1.27	-0.32	5.58	1.07	1.69	0.7	0.28	0.12	0.04
Total Debt/EBIT	-0.61	-0.4	-1.03	-0.89	-0.8	-1.09	-1.29	-1.24	-0.01	-0.08	-0.11	-0.04	-0.04	-0.04	-0.03
Net Debt/EBIT	-0.41	-0.31	-0.54	-0.48	-0.61	-0.51	-1.03	-0.32	5.51	1.05	1.6	0.67	0.26	0.11	0.04
EBITDA to Interest Expense	-5.11	-5.41	-3.6	-6.16	-12.44	-8.69	-7.42	-57.1	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-5.31	-5.41	-4.37	-6.19	-12.7	-9.26	-8.07	-63.58	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	-5.67	-6.42	-5.2	-8.61	-15.17	-12.1	-9.19	-57.71	- -	- -	- -	- -	- -	- -	- -
Interest Expense	1	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	36.7	58.75	74.98	76.84	70.01	71.46	65.22	74.31	97.41	91.56	91.46	89.04	86.8	73.93	72.37
Long-Term Debt/Equity (%)	- -	- -	12.02	12.73	14.4	5.75	35.98	5.29	- -	1.83	2.08	2.03	2.33	3.02	2.27
Long-Term Debt/Capital (%)	- -	- -	10.45	11	11.65	4.78	26.46	4.15	- -	1.79	2.02	1.98	2.26	2.88	2.19
Long-Term Debt/Total Assets (%)	- -	- -	9.35	10.15	10.45	4.25	23.43	3.93	- -	1.67	1.9	1.81	2.03	2.23	1.65
Total Debt/Equity (%)	66.11	16.08	15	15.73	23.58	20.21	35.98	27.61	0.15	2.02	3	2.54	3.23	4.71	3.76
Total Debt/Capital (%)	39.8	13.85	13.05	13.59	19.08	16.81	26.46	21.64	0.15	1.98	2.92	2.48	3.12	4.5	3.62
Total Debt/Total Assets (%)	26.55	10.07	11.67	12.55	17.11	14.95	23.43	20.52	0.15	1.85	2.75	2.27	2.8	3.48	2.72
Net Debt to Equity	44.4	12.52	7.9	8.47	17.99	9.52	28.66	7.06	-76.13	-27.16	-42.58	-43.17	-20.49	-14.49	-4.28
Net Debt/Capital (%)	30.75	11.13	7.32	7.81	15.25	8.69	22.27	6.59	-319.02	-36.38	-72.6	-73.45	-25.05	-16.4	-4.4
EBITDA	-7	-5	-2	-2	-4	-2	-2	-2	-5	-7	-8	-15	-11	-9	-7
EBITDA-CapEx	-7	-5	-2	-2	-4	-2	-2	-2	-5	-11	-10	-16	-12	-10	-7
Operating Income (Loss)	-8	-6	-2	-3	-4	-3	-2	-2	-5	-7	-9	-15	-12	-10	-7

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	03/31/2011	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025

Cash Ratio	0.24	0.13	0.58	1	0.34	0.47	1.87	0.71	29.17	6.34	6.18	4.29	1.77	0.51	0.18
Current Ratio	1	1.16	2.34	3.65	1.83	1.2	2.78	1.37	30.44	9.12	9.93	6.19	3.41	1.58	1.28
Quick Ratio	0.74	0.49	1.17	1.55	0.74	0.77	2.46	0.94	29.26	6.41	6.99	4.53	1.83	0.55	0.21
CFO/Avg Current Liab	-0.36	-0.91	0.18	-1.22	-1.49	-0.06	-0.62	-1.06	-2.07	-6.15	-5.01	-3.1	-3.25	-2.45	-1.77
Common Equity/Total Assets	36.7	58.75	74.98	76.84	70.01	71.46	65.22	74.31	97.41	91.56	91.46	89.04	86.8	73.93	72.37
Long-Term Debt/Equity (%)	- -	- -	12.02	12.73	14.4	5.75	35.98	5.29	- -	1.83	2.08	2.03	2.33	3.02	2.27
Long-Term Debt/Capital (%)	- -	- -	10.45	11	11.65	4.78	26.46	4.15	- -	1.79	2.02	1.98	2.26	2.88	2.19
Long-Term Debt/Total Assets (%)	- -	- -	9.35	10.15	10.45	4.25	23.43	3.93	- -	1.67	1.9	1.81	2.03	2.23	1.65
Total Debt/Equity (%)	66.11	16.08	15	15.73	23.58	20.21	35.98	27.61	0.15	2.02	3	2.54	3.23	4.71	3.76
Total Debt/Capital (%)	39.8	13.85	13.05	13.59	19.08	16.81	26.46	21.64	0.15	1.98	2.92	2.48	3.12	4.5	3.62
Total Debt/Total Assets (%)	26.55	10.07	11.67	12.55	17.11	14.95	23.43	20.52	0.15	1.85	2.75	2.27	2.8	3.48	2.72
CFO/Total Liabilities	-24.24	-53.18	13.2	-48.54	-46.29	-3.21	-35.36	-69.26	-372.9	-354.6	-352.48	-253.64	-310.85	-201.43	-168.18
CFO/CapEx	-9.23	-916.49	1.73	-205.31	-33.76	-1.29	-9.55	-9.61	-55.5	-1.94	-6.78	-9.68	-11.38	-10.1	-12.86
Altman's Z-Score	-3.14	-1.46	-0.05	-2.4	-3	-2.6	-4.85	-3.56	53.44	1.55	13.77	3.7	-6.02	-16.55	-22.06

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	03/31/2011	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025

Accounts Receivable Turnover	1.01	1.7	5.93	2.78	9.85	6.51	0.68	3.35	15.94	37.53	5.83	2.65	7.85	18.42	34.82
Days Sales Outstanding	362.65	215.28	61.56	131.1	37.06	56.07	539.47	109.09	22.9	9.73	62.59	137.91	46.48	19.81	10.48
Inventory Turnover	26.45	18.49	16.35	3.71	10.75	12.67	4.47	8.69	13.58	1.76	0.16	0.04	0.15	0.29	0.45
Days Inventory Outstanding	13.8	19.74	22.32	98.29	33.96	28.8	81.69	42.02	26.88	207.22	2,260.44	8,114.51	2,412.19	1,249.77	811.73
Accounts Payable Turnover	2.47	6.15	13.9	5.71	46.75	19.7	0.54	7.7	16.45	14.72	3.26	-2.37	-0.57	-0.77	0.57
Accounts Payable Turnover Days	148.01	59.34	26.27	63.91	7.81	18.53	681.64	47.4	22.19	24.8	111.96	-153.97	-644.29	-476.55	640.3
Cash Conversion Cycle	228.44	175.68	57.61	165.48	63.21	66.34	-60.48	103.71	27.59	192.14	2,211.08	8,406.38	3,102.96	1,746.13	181.92
Inventory to Cash Days	348.85	195.55	39.24	32.81	3.1	27.26	457.78	67.08	-3.98	-197.5	-2,197.85	-7,976.6	-2,365.71	-1,229.96	-801.25
Inventories	- -	- -	- -	1	1	- -	- -	- -	- -	4	5	4	3	2	1
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	2	2	1	1
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	4	2	1	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	- -	- -
Other Inventory	- -	- -	- -	1	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	03/31/2011	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025

Market Capitalization	8	29	19	7	6	12	13	17	82	19	86	48	18	27	23
- Cash & Cash Equivalents	2	1	1	1	1	1	1	2	26	7	15	10	3	1	- -
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	1	1	1	1	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	5	3	2	2	3	3	3	2	- -	1	1	1	- -	- -	- -
Enterprise Value	12	32	21	9	10	14	14	18	57	7	72	39	15	26	23
Total Capital	12	18	17	16	18	17	10	10	34	27	34	24	15	8	7
Total Debt/Capital (%)	39.8	13.85	13.05	13.59	19.08	16.81	26.46	21.64	0.15	1.98	2.92	2.48	3.12	4.5	3.62
Total Debt / EV	0.4	0.08	0.11	0.25	0.36	0.2	0.2	0.13	- -	0.07	0.01	0.02	0.03	0.01	0.01
EV/Sales	2.92	7.71	2.64	3.97	1.26	2.18	23.27	8.12	11.06	1.83	80.14	97.21	16.63	19.2	18
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	22.85	- -	- -	247	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	16.9	- -	- -	77.88	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	8	14	19	6	6	9	12	16	74	19	75	47	18	24	22
Diluted Enterprise Value	12	17	21	8	10	10	14	16	48	13	62	38	15	23	22
EV per Share	8	5.39	3.03	0.96	0.65	0.6	0.48	0.58	1.43	0.19	1.5	0.76	0.29	0.39	0.28
TTM Sales	4	4	8	2	8	6	1	2	5	4	1	- -	1	1	1
TTM EBITDA	-7	-5	-2	-2	-4	-2	-2	-2	-5	-7	-8	-15	-11	-9	-7
TTM Operating Income	-8	-6	-2	-3	-4	-3	-2	-2	-5	-7	-9	-15	-12	-10	-7
TTM Cash Flow to Firm	-1	-4	1	-1	-2	- -	-1	-2	-3	-9	-11	-7	-7	-5	-4
TTM Free Cash Flow to Firm	-1	-4	1	-1	-2	- -	-1	-2	-3	-4	-9	-7	-6	-5	-4

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	03/31/2011	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025

Price/Free Cash Flow	-3.47	-2.84	21.78	-3.69	-2.59	-239.92	-9.68	-9.04	-22.51	-4.6	-8.16	-7.09	-2.78	-5.02	-5.82
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	12	32	21	9	10	14	14	18	57	7	72	39	15	26	23
Low Price	5.1	1.42	1.13	0.71	0.38	0.14	0.19	0.3	0.25	0.26	0.41	0.74	0.28	0.25	0.26
EV/Sales	2.92	7.71	2.64	3.97	1.26	2.18	23.27	8.12	11.06	1.83	80.14	97.21	16.63	19.2	18
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-0.66	-1.26	-6.59	-3.5	-2.7	-1.76	-5.45	-8.53	-10.72	-5.39	-5.76	-4.55	-2.22	-1.47	-4.27
Price/Earnings High	-2.01	-2.78	-15.77	-7.6	-7.48	-4.84	-8.38	-25.5	-125.95	-13.17	-21.43	-15.48	-4.47	-2.26	-9.78
Price/Earnings Low	-0.38	-0.53	-3.5	-1.93	-1.22	-0.79	-2.61	-4.69	-2.16	-1.42	-1.96	-2.47	-1.27	-1.13	-2.8
Price/Book Value	1.21	1.98	1.35	0.54	0.46	0.9	1.81	2.14	2.45	0.73	2.61	2.03	1.21	3.64	3.64
Price/Book Value Average	1.96	1.36	1.03	0.89	0.88	0.52	1.52	2.08	1.46	1.48	1.76	2.92	1.73	2.97	5.08
Price/Book Value High	6.01	2.99	2.47	1.93	2.43	1.43	2.34	6.22	17.16	3.62	6.56	9.94	3.48	4.55	11.63
Price/Book Value Low	1.14	0.57	0.55	0.49	0.39	0.23	0.73	1.14	0.29	0.39	0.6	1.58	0.99	2.28	3.33
Price/Tangible Book Value	1.29	2.93	1.4	0.56	0.5	0.99	1.86	2.17	2.46	0.73	2.64	2.11	1.31	4.68	5.15
Price/Tangible Book Value Average	2.09	2.01	1.07	0.92	0.96	0.58	1.57	2.11	1.47	1.49	1.78	3.04	1.88	3.81	7.19
Price/Tangible Book Value High	6.4	4.43	2.57	1.99	2.67	1.59	2.41	6.32	17.25	3.65	6.64	10.33	3.78	5.84	16.43
Price/Tangible Book Value Low	1.21	0.85	0.57	0.51	0.43	0.26	0.75	1.16	0.3	0.39	0.61	1.65	1.08	2.92	4.71
Price/Sales	2	3.39	2.42	2.82	0.85	1.34	20.78	7.13	14.39	4.75	83.65	119.49	19.59	17.5	17.16
Price/Sales Average	3.26	2.33	1.85	4.66	1.62	0.78	17.55	6.94	8.58	9.69	56.48	172.07	28.09	14.24	23.95
Price/Sales High	9.98	5.13	4.42	10.11	4.5	2.14	26.98	20.77	100.87	23.66	210.28	585.54	56.43	21.87	54.78
Price/Sales Low	1.89	0.98	0.98	2.56	0.73	0.35	8.4	3.82	1.73	2.55	19.23	93.32	16.07	10.94	15.7
Price/Cash Flow	-3.1	-2.84	34.35	-3.67	-2.51	-54.03	-8.67	-8.1	-22.11	-2.23	-6.96	-6.36	-2.53	-4.53	-5.36
Price/Cash Flow Average	-5.04	-1.95	26.27	-6.08	-4.82	-31.43	-7.32	-7.89	-13.19	-4.55	-4.7	-9.15	-3.63	-3.68	-7.49
Price/Cash Flow High	-15.43	-4.29	62.9	-13.19	-13.36	-86.25	-11.26	-23.58	-154.97	-11.1	-17.48	-31.15	-7.3	-5.66	-17.13
Price/Cash Flow Low	-2.92	-0.82	13.96	-3.34	-2.17	-14.03	-3.5	-4.34	-2.66	-1.2	-1.6	-4.96	-2.08	-2.83	-4.91
Price/Free Cash Flow Average	-5.65	-1.95	16.65	-6.11	-4.97	-139.54	-8.18	-8.8	-13.43	-9.37	-5.51	-10.21	-3.98	-4.09	-8.12
Price/Free Cash Flow High	-17.3	-4.29	39.88	-13.25	-13.77	-382.96	-12.57	-26.32	-157.81	-22.88	-20.51	-34.74	-8	-6.28	-18.57
Price/Free Cash Flow Low	-3.28	-0.82	8.85	-3.36	-2.24	-62.29	-3.91	-4.84	-2.71	-2.47	-1.88	-5.54	-2.28	-3.14	-5.32
EV/Sales Average	4.16	5.51	2.07	6.08	2.04	1.39	22.95	7.91	4.58	8	49.27	150.91	25.37	15.51	25.18
EV/Sales High	10.78	11.29	4.65	12.3	4.91	3.32	33.34	23.13	107.58	21.91	224.57	573.17	53.99	24.15	57.77
EV/Sales Low	2.81	2.73	1.2	3.68	1.14	0.78	12.87	4.47	- -	0.89	6.82	70.49	13.25	11.77	16.46
EV/EBITDA Average	-2.38	-4.35	-11	-7.69	-4.39	-4.75	-8.04	-9.8	-5.12	-4.85	-5.37	-4.05	-2.12	-2.28	-4.58
EV/EBITDA High	-6.17	-8.91	-24.74	-15.56	-10.59	-11.35	-11.68	-28.65	-120.06	-13.28	-24.46	-15.4	-4.51	-3.55	-10.52
EV/EBITDA Low	-1.61	-2.15	-6.38	-4.66	-2.47	-2.66	-4.51	-5.54	3.42	-0.54	-0.74	-1.89	-1.11	-1.73	-3
EV/EBIT Average	-2.14	-3.66	-7.6	-5.5	-3.6	-3.41	-6.49	-9.69	-5.05	-4.74	-5.07	-3.88	-2	-2.13	-4.3
EV/EBIT High	-5.55	-7.5	-17.1	-11.14	-8.69	-8.16	-9.42	-28.35	-118.54	-13	-23.12	-14.75	-4.25	-3.32	-9.86
EV/EBIT Low	-1.45	-1.82	-4.41	-3.34	-2.02	-1.91	-3.64	-5.48	3.38	-0.53	-0.7	-1.81	-1.04	-1.62	-2.81
Last Price	5.4	4.9	2.78	0.78	0.44	0.52	0.47	0.56	2.08	0.49	1.79	0.95	0.34	0.4	0.28
High Price	26.9	7.4	5.1	2.8	2.34	0.83	0.61	1.63	14.58	2.44	4.5	4.65	0.98	0.5	0.91
Enterprise Value Average	17	23	17	14	16	9	13	17	23	33	44	60	23	21	32
Enterprise Value High	44	47	37	28	38	21	19	51	550	89	202	228	49	32	73
Enterprise Value Low	11	11	10	8	9	5	7	10	-16	4	6	28	12	16	21

Shares Outstanding	1	6	7	9	15	23	28	31	40	39	48	51	53	67	81
Diluted Weighted Avg Shares	2	3	7	8	15	16	26	28	35	39	42	50	53	59	77
Basic Weighted Avg Shares	2	3	7	8	15	16	26	28	35	39	42	50	53	59	77
Revenue per Share	2.7	1.44	1.15	0.28	0.52	0.39	0.02	0.08	0.14	0.1	0.02	0.01	0.02	0.02	0.02
EBITDA per Share	-4.71	-1.83	-0.22	-0.22	-0.24	-0.11	-0.06	-0.06	-0.13	-0.17	-0.2	-0.3	-0.21	-0.16	-0.09
Operating Income per Share	-5.23	-2.17	-0.31	-0.31	-0.29	-0.16	-0.08	-0.06	-0.13	-0.17	-0.21	-0.31	-0.22	-0.17	-0.1
Basic EPS, GAAP	-13.4	-2.66	-0.32	-0.37	-0.31	-0.17	-0.07	-0.06	-0.12	-0.19	-0.21	-0.3	-0.22	-0.22	-0.09
Basic EPS from Cont Ops	-13.91	-2.71	-0.33	-0.37	-0.32	-0.17	-0.07	-0.06	-0.12	-0.19	-0.21	-0.3	-0.22	-0.22	-0.09
Diluted EPS, GAAP	-13.4	-2.66	-0.32	-0.37	-0.31	-0.17	-0.07	-0.06	-0.12	-0.19	-0.21	-0.3	-0.22	-0.22	-0.09
Diluted EPS from Cont Ops	-13.91	-2.71	-0.33	-0.37	-0.32	-0.17	-0.07	-0.06	-0.12	-0.19	-0.21	-0.3	-0.22	-0.22	-0.09
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.74	-1.73	0.08	-0.21	-0.18	-0.01	-0.05	-0.07	-0.09	-0.22	-0.26	-0.15	-0.13	-0.09	-0.05
Free Cash Flow per Basic Share	-1.93	-1.73	0.03	-0.21	-0.18	-0.02	-0.06	-0.08	-0.1	-0.33	-0.3	-0.16	-0.15	-0.1	-0.06
Cash & Equivalents per Share	1.06	0.09	0.15	0.11	0.06	0.06	0.09	0.05	0.65	0.31	0.31	0.2	0.06	0.02	0.01
Book Value per Share	4.48	2.47	2.07	1.45	0.96	0.58	0.26	0.26	0.85	0.67	0.69	0.47	0.28	0.11	0.08
Tangible Book Value per Share	4.2	1.67	1.98	1.4	0.88	0.52	0.25	0.26	0.85	0.67	0.68	0.45	0.26	0.09	0.06

IGC Pharma, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)